• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

犬西沙必利中毒

Cisapride toxicosis in dogs.

作者信息

Volmer P A

机构信息

National Animal Poison Control Center, College of Veterinary Medicine, Urbana, IL 61801, USA.

出版信息

Vet Hum Toxicol. 1996 Apr;38(2):118-20.

PMID:8693686
Abstract

Cisapride is an oral prokinetic agent used to facilitate or restore motility in the gastrointestinal tract. The National Animal Control Center has received 17 reports of accidental overexposure of dogs to cisapride since 1994. Doses of 640 mg/kg in dogs were reported to be lethal, but severe clinical signs have been noted at acute exposures as low as 18 mg/kg. The most common signs include diarrhea, muscle tremors and fasciculations, ataxia and incoordination, and hyperthermia. Available treatment is symptomatic and supportive. Activated charcoal is effective in reducing plasma cisapride levels.

摘要

西沙必利是一种口服促动力剂,用于促进或恢复胃肠道的蠕动。自1994年以来,国家动物控制中心已收到17起犬类意外过量接触西沙必利的报告。据报道,犬类摄入640毫克/千克的剂量可致死,但急性接触低至18毫克/千克时就已出现严重的临床症状。最常见的症状包括腹泻、肌肉震颤和肌束颤动、共济失调和不协调以及体温过高。现有的治疗方法是对症和支持治疗。活性炭可有效降低血浆中西沙必利的水平。

相似文献

1
Cisapride toxicosis in dogs.犬西沙必利中毒
Vet Hum Toxicol. 1996 Apr;38(2):118-20.
2
Effect of prokinetic agents, cisapride and metoclopramide, on the bioavailability in humans and intestinal permeability in rats of ranitidine, and intestinal charcoal transit in rats.促动力药西沙必利和甲氧氯普胺对雷尼替丁人体生物利用度、大鼠肠道通透性及大鼠肠道炭末转运的影响。
Res Commun Mol Pathol Pharmacol. 2000 Nov-Dec;108(5-6):311-23.
3
[Prokinetic activity and antral inflammation. Usefulness of cisapride combined with H2 antagonists in gastritis].
Clin Ter. 1994 Jan;144(1):23-6.
4
Cisapride.西沙必利
Pediatr Nurs. 1994 Mar-Apr;20(2):202-3.
5
A risk-benefit assessment of cisapride in the treatment of gastrointestinal disorders.西沙必利治疗胃肠道疾病的风险效益评估。
Drug Saf. 1995 Jun;12(6):384-92. doi: 10.2165/00002018-199512060-00004.
6
Cisapride. An updated review of its pharmacology and therapeutic efficacy as a prokinetic agent in gastrointestinal motility disorders.西沙必利。作为胃肠动力障碍促动力剂的药理学及治疗效果的最新综述。
Drugs. 1994 Jan;47(1):116-52. doi: 10.2165/00003495-199447010-00008.
7
Accidental ingestion of acyclovir in dogs: 105 reports.犬意外摄入阿昔洛韦:105例报告。
Vet Hum Toxicol. 2000 Dec;42(6):370-1.
8
Accidental ingestion of alprazolam in 415 dogs.415只狗意外摄入阿普唑仑。
Vet Hum Toxicol. 2002 Feb;44(1):22-3.
9
Cisapride: a new class of prokinetic agent. The ACG Committee on FDA-related matters. American College of Gastroenterology.
Am J Gastroenterol. 1991 Feb;86(2):135-49.
10
Cisapride: a gastrointestinal prokinetic drug.
Ann Pharmacother. 1994 Apr;28(4):488-500. doi: 10.1177/106002809402800413.

引用本文的文献

1
Should cisapride have been "blacklisted"?西沙必利应该被“列入黑名单”吗?
Arch Dis Child Fetal Neonatal Ed. 2000 Jan;82(1):F3-4. doi: 10.1136/fn.82.1.f3.